Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
JCO Precis Oncol
Epub 2020 Jun 24.
Elizabeth K Lee
Katharine M Esselen
David L Kolin
Larissa J Lee
Ursula A Matulonis
Panagiotis A Konstantinopoulos
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA.
Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA.
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Boston, MA.
No abstract available
U10 CA180868/CA/NCI NIH HHS/United States
UM1 CA186709/CA/NCI NIH HHS/United States